Thermo Fisher Scientific Hits $12.14 Billion in Q3 Revenue as Innovation Fuels Double-Digit Earnings Growth

Revenue Grew 9% Including 6% Organic Revenue Growth Grew GAAP Diluted EPS 9% and Adjusted EPS 15% Outstanding perfor...

October 22, 2026 | Thursday | Company results
ESTEVE CDMO expands presence in Asia with major investment and new manufacturing site in China

ESTEVE CDMO, Esteve Healthcare contract development and manufacturing organization, is strengthening its presence in Asi...

October 22, 2026 | Thursday | News
Japan's Govt selects NovAccel's project to establish Global Actinium-225 Manufacturing Hub

NovAccel, Inc., a Japanese deep-tech company developing proprietary superconducting accelerator technology for medical r...

October 22, 2026 | Thursday | News
Korea's Samsung Bioepis enters into landmark 10-Year agreement to supply Eculizumab to Brazil

South Korea-based Samsung Bioepis has announced a landmark 10-year agreement with its local partners in Brazil—sta...

October 22, 2026 | Thursday | News
Healthcare’s AI Ambitions Are Colliding With a Data Wall

Healthcare is generating more data than ever, yet much of its potential remains locked within disconnected systems. As a...

October 21, 2026 | Wednesday | News
Asia-Pacific’s Cardiac Revolution: From Global Evidence Gap to Global Innovation Powerhouse

  Asia-Pacific stands at a defining moment in interventional cardiology, where technological advancement must be m...

October 21, 2026 | Wednesday | Analysis
From 200 Antibody Variants to One Winning Candidate: How Sartorius Is Accelerating Biologics Development

Artificial intelligence is reshaping biologics development by enabling faster antibody selection, early identification o...

October 21, 2026 | Wednesday | Opinion
Mubadala Bio inks strategic partnership with Marcyrl Group to localise broad portfolio of women’s health in UAE

Mubadala Bio has signed a strategic partnership with Marcyrl Pharmaceutical Industries (Marcyrl Group) to localise a bro...

October 22, 2026 | Thursday | News
Korea's NeuroXT receives US FDA 510(k) clearance for AI software supporting prognostic assessment in Mild Cognitive Impairment

South Korea-based startup NeuroXT Inc., a medical device manufacturer, has announced that NEXT-Cue, its AI-based Softwar...

October 21, 2026 | Wednesday | News
China's startup Metis TechBio strikes drug-delivery deal worth $1.1 B with Eli Lilly

METiS TechBio, the innovator in AI-powered drug delivery, has announced a strategic collaboration with US-based Eli Lill...

October 21, 2026 | Wednesday | News
Japan's Toho Holdings invests in biotech startup AdipoSeeds

Japan-based TOHO HOLDINGS has invested in AdipoSeeds, Inc., a venture company spun off from Keio University School of Me...

October 21, 2026 | Wednesday | News
Nxera Pharma Japan licenses Quviviq to Taiwan’s Synmosa Biopharma in 8 APAC markets

Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and com...

October 19, 2026 | Monday | News
Taiwan's Jyong Biotech to establish new manufacturing facility and US operations centre in Texas

Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of...

October 17, 2026 | Saturday | News
Merck inaugurates State-of-the-Art ADVANCE Bioanalytical Facility in US

Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facil...

October 19, 2026 | Monday | News
AtomVie inks strategic partnership with Jubilant Radiopharma to strengthen logistics and distribution in Clinical Trials

AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...

October 16, 2026 | Friday | News
Charles River collaborates with Magellan Stem Cells to advance regenerative medicine development

Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy fi...

October 16, 2026 | Friday | News
China's Brii Biosciences unveils BRiSC™, an siRNA Therapeutics discovery platform

Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...

October 16, 2026 | Friday | News
Japan's JCR Pharma receives marketing authorisation in Kuwait for Enzyme Replacement Therapy to treat Hunter Syndrome

Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...

October 15, 2026 | Thursday | News
The Future of FTIR Microscopy Lies in Smarter, Faster and More Precise Chemical Analysis

As laboratories across Asia-Pacific face growing demands for faster, more precise and reproducible analytical testing, F...

October 15, 2026 | Thursday | Opinion
Swiss firm Alentis Therapeutics partners with Korea's PinotBio to develop next-gen ADCs targeting claudin-1

Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...

October 15, 2026 | Thursday | News
New Sydney laboratory expands 360biolabs’ Australian network

360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...

October 15, 2026 | Thursday | News
Beyond Patent Expiry: Rethinking the Future of Mature Medicines in Asia-Pacific

As pharmaceutical innovation accelerates, mature medicines remain essential to healthcare systems, y...

October 14, 2026 | Wednesday | Opinion
Waters launches AI Link for advancing AI-enabled LC-MS workflows from research to release

US-based Waters Corporation has launched Waters AI Link, a software capability that brings Anthropic's Model Context Pro...

October 14, 2026 | Wednesday | News
Asieris Pharma partners with Theramex for global development of non-surgical treatment for cervical precancerous lesions in ANZ

Theramex, a London-headquartered specialty pharmaceutical company dedicated to women and their health, and China-based A...

October 13, 2026 | Tuesday | News
Roche inks $1.06 B deal with China's Rona Therapeutics for RNA-based metabolic therapies

Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...

October 14, 2026 | Wednesday | News